Healio6d
Subcutaneous adjuvant regimen for breast cancer reduces ‘time toxicity’ of treatment
Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...
Frontiers6d
Advances in myeloid cell targeting for overcoming tumor immunosuppression
Myeloid cells constitute essential components within the immunosuppressive microenvironment of various tumors, significantly influencing cancer progression ...
Cracking cancer's code: Research identifies novel drug target for acute myeloid leukemia treatment
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at ...
Acute Myeloid Leukemia Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
News Medical1mon
Distinct myeloid-derived suppressor cell populations fuel aggressive brain tumor growth
We found that the myeloid-derived suppressor cells and tumor stem cells literally were in the same place - a region described by pathologists in the 1980s as the pseudopalisading region.